Top Companies in Animal Wound Care Market

The animal wound care market is projected to reach USD 1.79 billion by 2030 from USD 1.28 billion by 2025, at a CAGR of 6.9% from 2025 to 2030.

The global animal wound care market is expected to grow due to several key factors. Firstly, there is increasing awareness of animal well-being, which motivates pet owners to invest more in their pets’ health, including wound care. Secondly, the rising trend of pet ownership means more people are choosing to have pets and are willing to spend on their health and well-being, including innovative and effective wound care products.

Additionally, advancements in veterinary medicine, such as improved surgical and wound care products, have made it easier and more effective to treat animal wounds. Lastly, the growing adoption of companion animals and the increasing prevalence of chronic diseases in animals have led to a larger population that requires wound care. Collectively, these factors are contributing to the growth of the animal wound care market, indicating significant potential for future expansion.

The major players in the global animal wound care market are 3M Company (US), Medtronic Plc (Ireland), B. Braun SE (Germany), Virbac (France), Neogen Corporation (US), Jorgen Kruuse A/S (Denmark), Sonoma Pharmaceuticals, Inc. (US), Ethicon, Inc. (US), Dechra Pharmaceuticals (UK), Zoetis Inc. (US), Jazz Medical, LLC (Ireland), KeriCure Inc. (US), Advancis Veterinary (UK), Vernacare Ltd. (UK), Creative Science (US), The Wound VAC Company, LLC (US), and Dômes Pharma, Inc. (France). Other players include companies such as PrimaVet Inc. (US), Innovacyn, Inc. (US), SilverGlide (Australia), Vetoquinol (France), Millpledge Ltd. (UK), Ovik Health (US), Hydrofera (US), Riverpoint Medical (US), Internacional Farmaceutica S.A. de C.V. (Mexico), and Orion Sutures India Pvt. Ltd. (India).

To know about the assumptions considered for the study download the pdf brochure

• In December 2024, Virbac acquired Moonsan in Turkey, enhancing its distribution capabilities for companion animal products. This acquisition will improve regional access and speed to market for dermatology and wound management products while expanding Virbac's presence in a fast-growing market.
• In November 2024, Sonoma Pharmaceuticals received FDA 510(k) clearance for its Microcyn hydrogel, which boasts improved biocompatibility and an extended shelf life. This clearance enhances clinical credibility and supports the expansion of wound care indications across both human and animal health in the US market.
• In May 2024, Sonoma launched MicrocynAH animal health products in the US, extending its hypochlorous acid wound and skin care line into veterinary channels. This move aims to build retail and clinical penetration and support broader brand expansion across various animal health applications.
• In March 2024, 3M completed the spin-off of its Health Care business as Solventum, establishing a focused medical company. This independent strategy has the potential to influence advanced wound care portfolios and supply dynamics, which may also be relevant in veterinary markets.
• In August 2023, Dômes Pharma acquired SentrX Animal Care to strengthen its leadership in veterinary ophthalmology and wound care. This acquisition will leverage SentrX’s BioHAnce hyaluronic acid platform and its presence in the US to accelerate North American expansion and expand global offerings in eye and wound therapies.

B. Braun SE (Germany)

B. Braun SE is a global medical technology company that offers more than 5,000 medical devices and pharmaceutical products across three key segments: Hospital Care, Aesculap, and Avitum. The Aesculap segment specializes in wound care, providing dressings for both dry and moist wound treatments, as well as advanced solutions for chronic wounds in both humans and animals.

The company has a strong presence in 64 countries, with subsidiaries including B. Braun VetCare SA in Spain and B. Braun Medical Pvt. Ltd. in India. B. Braun holds a leading position in the global animal wound care market, which is supported by its innovative product range and continuous investments in research and development. Since establishing its veterinary division in 2003, the company has focused on advancing medical technologies and providing training programs for veterinarians. Its extensive geographic reach and customer-focused initiatives contribute to its long-term market leadership.

Medtronic Plc (Ireland)

Medtronic Plc is a global leader in medical technology, manufacturing a wide range of medical devices, including equipment and therapies for veterinary use. The company's extensive product portfolio includes wound closure materials such as sutures, staplers, and tissue adhesives. Additionally, Medtronic has introduced a Negative Pressure Wound Therapy (NPWT) system designed to promote the healing of chronic wounds in animals.

Medtronic continually invests in research and development to create new and innovative products for animal wound care, giving the company a competitive edge in the global animal wound care market. It has also collaborated with various veterinary companies to expand its offerings for animal health and well-being. As a major player in medical devices, Medtronic’s presence in the animal wound care market enhances the significance of this area and drives further investment in this segment.

3M Company (US)

3M is a leading player in the animal wound care market, offering a wide range of innovative products and solutions for veterinarians and pet owners. The company provides advanced dressings, negative pressure wound therapy systems, and surgical tapes and adhesives, all designed to enhance animal care effectively. 3M continuously invests in research and development to introduce new and improved wound care products and solutions. The company collaborates with veterinarians and animal healthcare professionals to provide educational resources and training on the proper use of its animal wound care products.

With strong brand recognition and a diverse product portfolio, 3M aims to assist veterinarians and pet owners worldwide, giving the company a competitive edge in the global animal wound care market.

Market Ranking:

The animal wound care market is moderately consolidated, with a few leading players dominating the global landscape through innovation, product diversification, and extensive distribution networks.

3M Company (US) holds a strong position in the market due to its advanced wound management solutions and continuous investment in research and development, particularly in adhesive and antimicrobial technologies. Medtronic Plc (Ireland) utilizes its expertise in medical technology and broad product integration capabilities to provide effective surgical and wound healing solutions. B. Braun SE (Germany) is notable for its comprehensive range of veterinary wound dressings and infection prevention products, backed by strong clinical credibility. Virbac (France) has established a robust presence in the market through its specialized veterinary formulations and commitment to innovation in animal health. Dechra Pharmaceuticals (UK) enhances its market share through targeted acquisitions and offers a wide range of topical and dermatological products for companion animals. Collectively, these companies set high standards for quality, innovation, and global reach in animal wound care.

Related Reports:

Animal Wound Care Market by Product (Surgical (Sutures & Staplers), Advanced (Foam, Hydrocolloid, Hydrogel), Traditional (Tapes, Bandages)), Animal Type (Companion, Livestock), Distribution Channel (Retail, E-Commerce), End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com